Newsroom | 1621 results

Sorted by: Latest

Vitamins/Supplements
-

Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces that it will hold a conference call on Wednesday, March 4, 2026, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and fiscal year 2025, which ended December 31, 2025. The financial results will be reported in a press release after the close of regular stock market trading hours on Wed...
-

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion of its weight loss specialty by enabling providers to prescribe a Compounded Semaglutide Pill with the same active ingredient as Wegovy®**. This needle-free treatment joins a full suite of weight loss solutions designed to meet the specific needs and preferences of individual customers. By leveraging nearly a decade of infrastructur...
-

M2 Ingredients Launches M2 Center of Innovation to Transform Functional Mushroom Product Development

VISTA, Calif.--(BUSINESS WIRE)--M2 Ingredients, the largest vertically integrated functional mushroom grower and ingredient supplier in the Western Hemisphere, today announced the launch of the M2 Center of Innovation, a state-of-the-art food, beverage, and supplement R&D application lab designed to accelerate innovation and elevate industry standards for functional mushroom product development. The M2 Center of Innovation brings together the most experienced functional mushroom R&D tea...
-

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full year ended December 31, 2025 on Tuesday, February 17, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, Nick Johnson, President, and Jim Maloney...
-

ILS Gummies Announces Strategic Growth Partnership with Edgehill Management, ECP Growth, Patriot Capital, and Providence Investment Partners

MCKINNEY, Texas--(BUSINESS WIRE)--ILS Gummies, a leading full-service manufacturer of gummy supplement products, today announced a strategic growth partnership with a group of institutional capital providers led by Edgehill Management, alongside ECP Growth, Patriot Capital, and Providence Investment Partners. The partnership is designed to support ILS Gummies as it enters its next stage of expansion, focused on scaling operations and supporting long-term customer success across the nutraceutica...
-

Sensient Announces Conference Call

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2025 fourth quarter and year-end results at 8:30 a.m. CST on Friday, February 13, 2026. Investors may access the live webcast on the Company’s web site at investor.sensient.com. Alternatively, investors may join the conference call by contacting Chorus Call Inc. at (844) 492-3726 or (412) 317-1078. A webcast replay will be available on the Company’s web site following the...
-

Biocodex Introduces Fullify™, a First-of-Its-Kind Precision Probiotic Clinically Shown to Activate the Gut-Brain Pathway to Support Appetite Management

BEDMINSTER, N.J.--(BUSINESS WIRE)--In a supplement category long dominated by stimulants, appetite suppressants and short-term fixes, Biocodex is introducing a fundamentally different approach. The science-driven health & wellness company behind Florastor® recently announced the U.S. launch of Fullify™, a first-of-its-kind precision probiotic developed to support appetite management and weight loss by working with the body’s natural gut-brain signaling. Developed in France and now available...
-

Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, announced that it’s heading back to the Big Game this year. On February 8th, Hims & Hers will follow up its hit “Sick of the System” ad, debuting a new national spot “Rich People Live Longer” with a simple message: the era of health as a luxury good is over, and proactive, life-changing care belongs to everyone. The campaign centers on the uncomfortable tru...
-

Samenvatting: SFI Health™ EMEA kondigt de lancering aan van Equazen ® Forte in Polen; een nieuw hoofdstuk op het gebied van cognitieve ondersteuning voor jongvolwassenen en volwassenen

LUGANO, Zwitserland--(BUSINESS WIRE)--SFI Health™ EMEA, de regionale entiteit van SFI Health™, wereldwijd toonaangevend op het gebied van natuurlijke gezondheidszorg, kondigt vandaag met trots de lancering aan van Equazen® Forte in Polen. Deze nieuwe geconcentreerde omega 3-productformule wordt toegevoegd aan het Equazen®-assortiment en is ontworpen om de normale cognitieve prestaties van jongvolwassenen en volwassenen te ondersteunen. Deze bekendmaking is officieel geldend in de originele bron...
-

Resumen: SFI Health™ EMEA anuncia el lanzamiento en Polonia de Equazen® Forte y abre un nuevo capítulo en el apoyo cognitivo para adultos jóvenes y adultos.

LUGANO, Suiza--(BUSINESS WIRE)--SFI Health™ EMEA, entidad regional de SFI Health™, líder mundial en salud natural, acaba de anunciar el lanzamiento de Equazen® Forte en Polonia, una nueva fórmula concentrada de omega 3 que se incorpora a la gama Equazen® y que está diseñada para apoyar el rendimiento cognitivo normal de jóvenes y adultos. El comunicado en el idioma original es la versión oficial y autorizada del mismo. Esta traducción es solamente un medio de ayuda y deberá ser comparada con el...